Delcath Systems Inc (DCTH) - Financial and Strategic SWOT Analysis Review

October 2021 | 51 pages | ID: D4A37432502EN
GlobalData

Abstracts

Delcath Systems Inc (DCTH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Delcath Systems Inc (Delcath) specializes in developing percutaneous hepatic perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of chemotherapeutic agents to the liver, while preventing them from entering the patient's bloodstream. The company’s lead product Melphalan Hydrochloride for Injection for use with the proprietary Delcath Hepatic Delivery System (HEPZATO KIT) to administer high dose chemotherapy to the liver. The company sells its proprietary system to deliver and filter melphalan hydrochloride in Europe under the trade name, Delcath Chemosat Hepatic Delivery System for Melphalan (Chemosat). Delcath is headquartered in New York, the US.

Delcath Systems Inc Key Recent Developments

Aug 10,2021: Delcath Systems Announces Second Quarter 2021 Results
Jul 28,2021: Delcath Systems Schedules Conference Call to Report 2021 Second Quarter Financial Results
Jul 07,2021: Delcath Systems to Present at Access to Giving Virtual Conference on July 13, 2021
Jun 08,2021: Delcath Systems set to join Russell Microcap Index
May 26,2021: Delcath Systems to Present at Jefferies Virtual Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Delcath Systems Inc - Key Facts
Delcath Systems Inc - Key Employees
Delcath Systems Inc - Key Employee Biographies
Delcath Systems Inc - Major Products and Services
Delcath Systems Inc - History
Delcath Systems Inc - Company Statement
Delcath Systems Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Delcath Systems Inc - Business Description
Business Segment: Other Revenue
Performance
Business Segment: Product Revenue
Performance
R&D Overview
Delcath Systems Inc - Corporate Strategy
Delcath Systems Inc - SWOT Analysis
SWOT Analysis - Overview
Delcath Systems Inc - Strengths
Delcath Systems Inc - Weaknesses
Delcath Systems Inc - Opportunities
Delcath Systems Inc - Threats
Delcath Systems Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Delcath Systems Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 10, 2021: Delcath Systems Announces Second Quarter 2021 Results
Jul 28, 2021: Delcath Systems Schedules Conference Call to Report 2021 Second Quarter Financial Results
Jul 07, 2021: Delcath Systems to Present at Access to Giving Virtual Conference on July 13, 2021
Jun 08, 2021: Delcath Systems set to join Russell Microcap Index
May 26, 2021: Delcath Systems to Present at Jefferies Virtual Healthcare Conference
May 11, 2021: Delcath Systems Announces First Quarter 2021 Results
Apr 30, 2021: Delcath Systems Announces Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
Mar 31, 2021: Delcath Systems Announces Fourth Quarter 2020 Results, Highlights Preliminary Positive FOCUS Trial Results; Conference Call at 8:00am Eastern Time
Mar 24, 2021: Delcath Systems Schedules Conference Call to Report 2020 Fourth Quarter Financial Results
Feb 11, 2021: Delcath Systems to Participate at Upcoming Virtual Investor Conferences

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Delcath Systems Inc, Key Facts
Delcath Systems Inc, Key Employees
Delcath Systems Inc, Key Employee Biographies
Delcath Systems Inc, Major Products and Services
Delcath Systems Inc, History
Delcath Systems Inc, Other Locations
Delcath Systems Inc, Subsidiaries
Delcath Systems Inc, Key Competitors
Delcath Systems Inc, Ratios based on current share price
Delcath Systems Inc, Annual Ratios
Delcath Systems Inc, Annual Ratios (Cont...1)
Delcath Systems Inc, Annual Ratios (Cont...2)
Delcath Systems Inc, Interim Ratios
Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Delcath Systems Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Delcath Systems Inc, Performance Chart (2016 - 2020)
Delcath Systems Inc, Ratio Charts
Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021